Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer
- PMID: 17084579
- DOI: 10.1016/j.ejso.2006.09.032
Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer
Abstract
Aims: Clinically palpable lymph nodes (LNs) are regarded as a contraindication for performing the sentinel node (SN) procedure. Many studies have shown, however, that clinical assessment of axillary LNs is inaccurate. This study evaluated the reliability of clinical axillary LN assessment by experts and assessed whether inaccuracy can be related to LN size.
Methods: Three hundred and one consecutive breast cancer patients undergoing either axillary dissection or SN were studied prospectively.
Results: The risk of having metastasis to the LN was 40.4% if the preoperative clinical assessment was "non-palpable LN", 61.5% if the assessment was "palpable but benign LN" and 84.4% if it was "suspicious LN". There were no clinically significant differences in mean size either when the LN was palpable versus non-palpable, or when the LN had metastasis or not.
Conclusions: The clinical assessment of axillary LNs as a criterion for offering the SN procedure is of little value.
Similar articles
-
Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?J Am Coll Surg. 2005 Jan;200(1):10-4. doi: 10.1016/j.jamcollsurg.2004.09.010. J Am Coll Surg. 2005. PMID: 15631914
-
Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?Chir Ital. 2007 Sep-Oct;59(5):693-9. Chir Ital. 2007. PMID: 18019642
-
Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.Eur J Surg Oncol. 2009 Apr;35(4):380-6. doi: 10.1016/j.ejso.2008.07.009. Epub 2008 Aug 30. Eur J Surg Oncol. 2009. PMID: 18757165
-
Axillary management after sentinel lymph node biopsy in breast cancer patients.Surg Clin North Am. 2007 Apr;87(2):365-77, ix. doi: 10.1016/j.suc.2007.01.014. Surg Clin North Am. 2007. PMID: 17498532 Review.
-
[Sentinel node biopsy in invasive breast cancer in 2007].Gynecol Obstet Fertil. 2007 Sep;35(9):731-42. doi: 10.1016/j.gyobfe.2007.04.023. Epub 2007 Aug 13. Gynecol Obstet Fertil. 2007. PMID: 17706450 Review. French.
Cited by
-
Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women.World J Surg. 2013 Jan;37(1):67-71. doi: 10.1007/s00268-012-1788-5. World J Surg. 2013. PMID: 22976793
-
Accuracy of individual descriptors and grading of nodal involvement by axillary ultrasound in patients of breast cancer.Int J Breast Cancer. 2013;2013:930596. doi: 10.1155/2013/930596. Epub 2013 Dec 19. Int J Breast Cancer. 2013. PMID: 24455284 Free PMC article.
-
Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters.Sci Rep. 2019 Oct 7;9(1):14356. doi: 10.1038/s41598-019-50898-3. Sci Rep. 2019. PMID: 31591439 Free PMC article.
-
An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment.BMC Cancer. 2017 May 31;17(1):389. doi: 10.1186/s12885-017-3380-8. BMC Cancer. 2017. PMID: 28569197 Free PMC article.
-
Can We Avoid Axillary Lymph Node Dissection (ALND) in Patients with 1-2 Positive Sentinel/Low Axillary Lymph Nodes (SLN/LAS+) in the Indian Setting?Indian J Surg Oncol. 2021 Jun;12(2):272-278. doi: 10.1007/s13193-021-01297-6. Epub 2021 Mar 2. Indian J Surg Oncol. 2021. PMID: 34295070 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical